These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 21439442

  • 1. Natural history of multiple sclerosis: long-term prognostic factors.
    Renoux C.
    Neurol Clin; 2011 May; 29(2):293-308. PubMed ID: 21439442
    [Abstract] [Full Text] [Related]

  • 2. Natural history of multiple sclerosis: risk factors and prognostic indicators.
    Vukusic S, Confavreux C.
    Curr Opin Neurol; 2007 Jun; 20(3):269-74. PubMed ID: 17495619
    [Abstract] [Full Text] [Related]

  • 3. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 4. Prognostic factors in multiple sclerosis.
    Bergamaschi R.
    Int Rev Neurobiol; 2007 Mar; 79():423-47. PubMed ID: 17531853
    [Abstract] [Full Text] [Related]

  • 5. Age at disability milestones in multiple sclerosis.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [Abstract] [Full Text] [Related]

  • 6. Natural history of multiple sclerosis: early prognostic factors.
    Mowry EM.
    Neurol Clin; 2011 May; 29(2):279-92. PubMed ID: 21439441
    [Abstract] [Full Text] [Related]

  • 7. The natural history of multiple sclerosis with childhood onset.
    Renoux C, Vukusic S, Confavreux C.
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [Abstract] [Full Text] [Related]

  • 8. Relapses and progression of disability in multiple sclerosis.
    Confavreux C, Vukusic S, Moreau T, Adeleine P.
    N Engl J Med; 2000 Nov 16; 343(20):1430-8. PubMed ID: 11078767
    [Abstract] [Full Text] [Related]

  • 9. The natural history of multiple sclerosis.
    Deshpande R, Kremenchutzky M, Rice GP.
    Adv Neurol; 2006 Nov 16; 98():1-15. PubMed ID: 16400823
    [No Abstract] [Full Text] [Related]

  • 10. New perspectives in the natural history of multiple sclerosis.
    Tremlett H, Zhao Y, Rieckmann P, Hutchinson M.
    Neurology; 2010 Jun 15; 74(24):2004-15. PubMed ID: 20548045
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors of multiple sclerosis in Lebanon.
    Yamout B, Itani S, Arabi A, Hamzeh D, Yaghi S.
    Int J Neurosci; 2010 Mar 15; 120(3):206-10. PubMed ID: 20374088
    [Abstract] [Full Text] [Related]

  • 12. Natural history of multiple sclerosis: have available therapies impacted long-term prognosis?
    Trojano M, Paolicelli D, Tortorella C, Iaffaldano P, Lucchese G, Di Renzo V, D'Onghia M.
    Neurol Clin; 2011 May 15; 29(2):309-21. PubMed ID: 21439443
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K, Khader Y.
    Clin Neurol Neurosurg; 2007 Jan 15; 109(1):32-7. PubMed ID: 16870328
    [Abstract] [Full Text] [Related]

  • 14. Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.
    Sotgiu S, Mameli G, Serra C, Zarbo IR, Arru G, Dolei A.
    Mult Scler; 2010 Oct 15; 16(10):1248-51. PubMed ID: 20685761
    [Abstract] [Full Text] [Related]

  • 15. Benign multiple sclerosis in Crete.
    Mastorodemos V, Nikolakaki H, Tzagournissakis M, Kotzamani D, Panou T, Spanaki C, Klados G, Maris T, Kontolaimaki E, Psaroudaki K, Chlouverakis G, Georgakakis G, Plaitakis A.
    Mult Scler; 2010 Jun 15; 16(6):701-6. PubMed ID: 20237192
    [Abstract] [Full Text] [Related]

  • 16. The natural history of multiple sclerosis: update 1998.
    Weinshenker BG.
    Semin Neurol; 1998 Jun 15; 18(3):301-7. PubMed ID: 9817534
    [Abstract] [Full Text] [Related]

  • 17. [The natural history of multiple sclerosis].
    Confavreux C, Vukusic S.
    Rev Prat; 2006 Jun 30; 56(12):1313-20. PubMed ID: 16948219
    [Abstract] [Full Text] [Related]

  • 18. Long-term prognosis of multiple sclerosis in Australia.
    McLeod JG, Barnett MH, Macaskill P, Williams DB.
    J Neurol Sci; 2007 May 15; 256(1-2):35-8. PubMed ID: 17368674
    [Abstract] [Full Text] [Related]

  • 19. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
    Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sørensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sá M, Salemi G, Savettieri G, Hillert J, Compston DA.
    Neurology; 2005 Apr 12; 64(7):1144-51. PubMed ID: 15824338
    [Abstract] [Full Text] [Related]

  • 20. Predictors of relapse rate in MS clinical trials.
    Held U, Heigenhauser L, Shang C, Kappos L, Polman C, Sylvia Lawry Centre for MS Research.
    Neurology; 2005 Dec 13; 65(11):1769-73. PubMed ID: 16344520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.